(IPX) IperionX American - Ratings and Ratios
Titanium, Powders, Metals
Description: IPX IperionX American
IperionX Limited (NASDAQ:IPX) is a Diversified Metals & Mining company with a market capitalization of $1.31 billion. The stock has demonstrated significant price appreciation, with a 52-week high of $41.84 and a low of $12.98, indicating substantial volatility.
The companys financials indicate a negative Return on Equity (RoE) of -0.04, suggesting that it is currently unprofitable. The absence of a forward Price-to-Earnings (P/E) ratio further implies that the company is not expected to generate earnings in the near future. This could be due to various factors, including high operational costs, research and development expenses, or investment in growth initiatives.
To evaluate IPXs potential, key economic drivers such as commodity prices, production costs, and demand for its products should be considered. The companys diversified metals and mining portfolio may provide a hedge against market fluctuations, but it also introduces complexity and potential operational risks. Key Performance Indicators (KPIs) to monitor include revenue growth, production volumes, and cash flow management.
From a trading perspective, IPXs beta of 0.388 suggests that the stock is relatively less volatile than the overall market. However, the Average True Range (ATR) of 1.59, representing a 3.79% daily price movement, indicates that the stock still experiences significant daily fluctuations. The stocks short-term and long-term moving averages (SMA20, SMA50, and SMA200) suggest a bullish trend, with the short-term averages above the long-term averages.
To make an informed investment decision, it is essential to analyze IPXs financial statements, managements guidance, and industry trends. A thorough examination of the companys quarterly tax provision and other financial metrics can provide insights into its profitability, cash flow, and overall financial health.
IPX Stock Overview
| Market Cap in USD | 1,311m |
| Sub-Industry | Diversified Metals & Mining |
| IPO / Inception | 2022-06-21 |
IPX Stock Ratings
| Growth Rating | 82.6% |
| Fundamental | 35.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 109% |
| Analyst Rating | 5.0 of 5 |
IPX Dividends
Currently no dividends paidIPX Growth Ratios
| Growth Correlation 3m | 93.8% |
| Growth Correlation 12m | 45.3% |
| Growth Correlation 5y | 94.9% |
| CAGR 5y | 78.39% |
| CAGR/Max DD 5y | 1.19 |
| Sharpe Ratio 12m | 0.18 |
| Alpha | 131.68 |
| Beta | 1.474 |
| Volatility | 75.53% |
| Current Volume | 40.2k |
| Average Volume 20d | 58.9k |
| Stop Loss | 42.1 (-5%) |
| Signal | 0.16 |
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-27.6k TTM) > 0 and > 6% of Revenue (6% = 40.7k TTM) |
| FCFTA -0.23 (>2.0%) and ΔFCFTA 31.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| error: NWC/Revenue cannot be calculated (needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.00 (>3.0%) and CFO -22.4k > Net Income -27.6k (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 11.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (27.1m) change vs 12m ago 28.93% (target <= -2.0% for YES) |
| error: Gross Margin (current vs previous) cannot be calculated (needs Total Revenue and Cost Of Revenue) |
| Asset Turnover 0.91% (prev 0.0%; Δ 0.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.37 (EBITDA TTM -32.6k / Interest Expense TTM 90.4k) >= 6 (WARN >= 3) |
Altman Z'' 12.32
| (A) 0.62 = (Total Current Assets 78.8m - Total Current Liabilities 6.67m) / Total Assets 115.8m |
| (B) -0.78 = Retained Earnings (Balance) -90.1m / Total Assets 115.8m |
| (C) -0.00 = EBIT TTM -33.0k / Avg Total Assets 74.9m |
| (D) 10.26 = Book Value of Equity 105.5m / Total Liabilities 10.3m |
| Total Rating: 12.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.42
| 1. Piotroski 0.0pt = -5.0 |
| 2. FCF Yield -2.16% = -1.08 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.04 = 2.50 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC -11.48% = -12.50 |
| 7. RoE -0.04% = -0.01 |
| 8. Revenue Trend data missing |
| 9. Rev. CAGR 0.0% = 0.0 |
| 10. EPS Trend 60.04% = 1.50 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of IPX shares?
Over the past week, the price has changed by +5.93%, over one month by +9.19%, over three months by +90.95% and over the past year by +143.92%.
Is IperionX American a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IPX is around 55.16 USD . This means that IPX is currently undervalued and has a potential upside of +24.46% (Margin of Safety).
Is IPX a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.7 | 0.8% |
| Analysts Target Price | 35 | -21% |
| ValueRay Target Price | 63.1 | 42.4% |
Last update: 2025-08-23 04:41
IPX Fundamental Data Overview
CCE Cash And Equivalents = 77.1m USD (Cash And Short Term Investments, last quarter)
Revenue TTM is 0, using Net Income TTM -27.6k + Cost of Revenue 706.6k = 679.0k USD
P/E Forward = 1250.0
P/B = 12.4178
Beta = 0.388
Revenue TTM = 679.0k USD
EBIT TTM = -33.0k USD
EBITDA TTM = -32.6k USD
Long Term Debt = 3.61m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 577.2k USD (from shortTermDebt, last quarter)
Debt = 4.19m USD (Calculated: Short Term 577.2k + Long Term 3.61m)
Net Debt = -72.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.24b USD (1.31b + Debt 4.19m - CCE 77.1m)
Interest Coverage Ratio = -0.37 (Ebit TTM -33.0k / Interest Expense TTM 90.4k)
FCF Yield = -2.16% (FCF TTM -26.7m / Enterprise Value 1.24b)
FCF Margin = -3929 % (FCF TTM -26.7m / Revenue TTM 679.0k)
Net Margin = -4.06% (Net Income TTM -27.6k / Revenue TTM 679.0k)
Gross Margin = -4.06% ((Revenue TTM 679.0k - Cost of Revenue TTM 706.6k) / Revenue TTM)
Tobins Q-Ratio = 11.73 (Enterprise Value 1.24b / Book Value Of Equity 105.5m)
Interest Expense / Debt = 2.16% (Interest Expense 90.4k / Debt 4.19m)
Taxrate = 21.0% (US default)
NOPAT = -33.0k (EBIT -33.0k, no tax applied on loss)
Current Ratio = 11.80 (Total Current Assets 78.8m / Total Current Liabilities 6.67m)
Debt / Equity = 0.04 (Debt 4.19m / last Quarter total Stockholder Equity 105.5m)
Debt / EBITDA = -128.6 (Net Debt -72.9m / EBITDA -32.6k)
Debt / EBITDA = -128.6 --> set to None
Debt / FCF = -0.16 (Debt 4.19m / FCF TTM -26.7m)
Total Stockholder Equity = 78.4m (last 4 quarters mean)
RoA = -0.02% (Net Income -27.6k, Total Assets 115.8m )
RoE = -0.04% (Net Income TTM -27.6k / Total Stockholder Equity 78.4m)
RoCE = -0.04% (Ebit -33.0k / (Equity 78.4m + L.T.Debt 3.61m))
RoIC = -0.06% (NOPAT -33.0k / Invested Capital 51.4m)
WACC = 11.42% (E(1.31b)/V(1.31b) * Re(11.45%)) + (D(4.19m)/V(1.31b) * Rd(2.16%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 97.50 | Cagr: 19.65%
Discount Rate = 11.45% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -26.7m)
Revenue Correlation: N/A | Revenue CAGR: 0.0%
Rev Growth-of-Growth: N/A
EPS Correlation: 60.04 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 103.0
Additional Sources for IPX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle